Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1999;100:1338-1345

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Qi, X.-L.
Right arrow Articles by Rouleau, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Qi, X.-L.
Right arrow Articles by Rouleau, J. L.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CAPTOPRIL
Medline Plus Health Information
*Heart Attack
Related Collections
Right arrow Cardiovascular Pharmacology
Right arrow Animal models of human disease
Right arrow Acute myocardial infarction
Right arrow Endothelium/vascular type/nitric oxide

(Circulation. 1999;100:1338-1345.)
© 1999 American Heart Association, Inc.


Basic Science Reports

Improvement of Endocardial and Vascular Endothelial Function on Myocardial Performance by Captopril Treatment in Postinfarct Rat Hearts

Xiu-Ling Qi, MD; Duncan J. Stewart, MD; Hugues Gosselin, DT; Azar Azad, PhD; Pierre Picard, PhD; Luc Andries, MD; Stanislas U. Sys, MD; Dirk L. Brutsaert, MD; Jean L. Rouleau, MD

From the Department of Medicine, Montreal Heart Institute, Montreal, Quebec (X.-L.Q., H.G., J.L.R.), and the Department of Medicine, St-Michael's Hospital, Toronto, Ontario (D.J.S., A.A., P.P.), Canada; and the Department of Physiology, University of Antwerp, Belgium (L.A., S.U.S., D.L.B.).

Correspondence to Dr Jean L. Rouleau, The Toronto Hospital, Division of Cardiology, 13EN-212–200 Elizabeth St, Toronto, Ontario M5G 2C4, Canada. E-mail jrouleau{at}torhosp.toronto.on.ca

Background—Endocardial (EE) and myocardial capillary vascular endothelial (myocap VE) cells have been shown to modulate the contractile characteristics of myocardium in a calcium-dependent manner. We evaluated the endothelial-myocardial interaction in the rat postinfarction myocardial infarction (MI) model and the effects of captopril.

Methods and Results—Wistar rats were divided into 4 groups treated for 4 weeks: (1) control; (2) infarcted controls (left anterior coronary artery ligation); (3) infarcted+captopril 2 g/L in drinking water; and (4) infarct+captopril+triton intracoronary injection. Coronary VE function was evaluated by infusion of serotonin in Langendorff preparations (n=31), and the myocardial contractile characteristics were investigated by use of isolated papillary muscles (n=44). Cardiac mRNA for endothelial constitutive nitric oxide synthase (ecNOS) was measured, and its cellular location was evaluated by immunohistochemistry. Serotonin-induced increase in coronary flow was decreased in infarct controls compared with controls (4.6% versus 53.4%, P<0.01) but not in the 2 infarct+captopril groups. Intracoronary triton injection decreased serotonin-induced coronary flow in the infarct+captopril+triton group. All MI groups had decreased total tension in isolated papillary muscles. EE removal by triton immersion decreased total tension in all groups except for infarct controls (3.3 versus 3.2 g/mm2). Cardiac ecNOS mRNA decreased in the control infarct group but remained normal in the infarct+captopril group.

Conclusions—Chronic postinfarction endothelium-induced coronary vasodilatation is impaired, and both EE and myocap VE dysfunction contribute to myocardial depression. Captopril use prevents these abnormalities and the reduction of cardiac ecNOS mRNA.


Key Words: myocardial infarction • endothelium • contractility • heart failure




This article has been cited by other articles:


Home page
J CARDIOVASC PHARMACOL THERHome page
N. S. Dhalla, M. R. Dent, P. S. Tappia, R. Sethi, J. Barta, and R. K. Goyal
Subcellular Remodeling as a Viable Target for the Treatment of Congestive Heart Failure
Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2006; 11(1): 31 - 45.
[Abstract] [PDF]


Home page
CirculationHome page
U. Landmesser, N. Engberding, F. H. Bahlmann, A. Schaefer, A. Wiencke, A. Heineke, S. Spiekermann, D. Hilfiker-Kleiner, C. Templin, D. Kotlarz, et al.
Statin-Induced Improvement of Endothelial Progenitor Cell Mobilization, Myocardial Neovascularization, Left Ventricular Function, and Survival After Experimental Myocardial Infarction Requires Endothelial Nitric Oxide Synthase
Circulation, October 5, 2004; 110(14): 1933 - 1939.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
D. L. Brutsaert
Cardiac Endothelial-Myocardial Signaling: Its Role in Cardiac Growth, Contractile Performance, and Rhythmicity
Physiol Rev, January 1, 2003; 83(1): 59 - 115.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. Bauersachs, M. Heck, D. Fraccarollo, S. K. Hildemann, G. Ertl, M. Wehling, and M. Christ
Addition of spironolactone to angiotensin-converting enzyme inhibition in heart failure improves endothelial vasomotor dysfunction: Role of vascular superoxide anion formation and endothelial nitric oxide synthase expression
J. Am. Coll. Cardiol., January 16, 2002; 39(2): 351 - 358.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Bauersachs, P. Galuppo, D. Fraccarollo, M. Christ, and G. Ertl
Improvement of Left Ventricular Remodeling and Function by Hydroxymethylglutaryl Coenzyme A Reductase Inhibition With Cerivastatin in Rats With Heart Failure After Myocardial Infarction
Circulation, August 28, 2001; 104(9): 982 - 985.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
A. I. M. Al-Shafei, R. G. Wise, G. A. Gresham, G. Bronns, T. A. Carpenter, L. D. Hall, and C. L.-H. Huang
Non-invasive magnetic resonance imaging assessment of myocardial changes and the effects of angiotensin-converting enzyme inhibition in diabetic rats
J. Physiol., January 9, 2002; 538(2): 541 - 553.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
A. I. M. Al-Shafei, R. G. Wise, G. A. Gresham, T. A. Carpenter, L. D. Hall, and C. L.-H. Huang
Magnetic resonance imaging analysis of cardiac cycle events in diabetic rats: the effect of angiotensin-converting enzyme inhibition
J. Physiol., January 9, 2002; 538(2): 555 - 572.
[Abstract] [Full Text] [PDF]